Lyra Therapeutics Inc (LYRA) Directors and Executive Officers - CSIMarket
CSIMarket
 
Lyra Therapeutics Inc   (NASDAQ: LYRA)

Lyra Therapeutics Inc

Officers & Directors


James R. Tobin
Director

Harlan Waksal, M.D.
Executive Chair and Chairperson of the Board

W. Bradford Smith
Director

Edward T. Anderson
Director

Nancy Snyderman, M.D., FACS
Director

Maria Palasis, Ph.D.
President, Chief Executive Officer and Director (principal executive officer)

C. Ann Merrifield
Director

Michael Altman
Director

Konstantin Poukalov
Director

Jason Cavalier
Chief Financial Officer and Treasurer (principal financial officer and principal accounting officer) ,

Lyra Therapeutics Inc currently has 27 employees.






LYRA Management Effectiveness LYRA Revenue per Employee LYRA Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.